Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report
Dabigatran is used for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is still unclear whether the use of dabigatran leads to more bleeding compared with warfarin. In this paper, we present a case of intraperitoneal hemorrhage in a 54-years-old ma...
Main Authors: | Egemen Cebeci, Nilay Şengül Samancı, Meltem Gürsu, Abdullah Şumnu, Serhat Karadağ, Sami Uzun, Emel Tatlı, Ahmet Behlül, Leyla Koç, Zeki Aydın, Savaş Öztürk |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2016-06-01
|
Series: | Haseki Tıp Bülteni |
Subjects: | |
Online Access: | http://www.hasekidergisi.com/article_10730/Intraperitoneal-Hemorrhage-In-A-Peritoneal-Dialysis-Patient-Using-Dabigatran-A-Case-Report |
Similar Items
-
Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
by: Jong-Min Kim, et al.
Published: (2022-01-01) -
Inflammation, Left Ventricular Mass Index and Chronic Renal Failure in Diabetic Patients
by: Egemen Cebeci, et al.
Published: (2020-03-01) -
The new way of Dabigatran reversal – Idarucizumab
by: Erwin Ciechański, et al.
Published: (2019-02-01) -
The new way of Dabigatran reversal – Idarucizumab
by: Erwin Ciechański, et al.
Published: (2019-02-01) -
Pharmacokinetics and Pharmacogenetics of Dabigatran
by: A. V. Savinova, et al.
Published: (2021-03-01)